Principal Financial Group’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.1M | Sell |
1,003,400
-60,709
| -6% | -$2.85M | 0.02% | 471 |
|
|
2025
Q1 | $47M | Sell |
1,064,109
-39,749
| -4% | -$1.75M | 0.03% | 462 |
|
|
2024
Q4 | $39.9M | Buy |
1,103,858
+185,413
| +20% | +$6.7M | 0.02% | 535 |
|
|
2024
Q3 | $29.4M | Buy |
918,445
+464,903
| +103% | +$14.9M | 0.02% | 647 |
|
|
2024
Q2 | $17.1M | Buy |
453,542
+436,598
| +2,577% | +$16.4M | 0.01% | 962 |
|
|
2024
Q1 | $834K | Buy |
16,944
+824
| +5% | +$40.6K | ﹤0.01% | 1892 |
|
|
2023
Q4 | $588K | Buy |
16,120
+1,231
| +8% | +$44.9K | ﹤0.01% | 1926 |
|
|
2023
Q3 | $344K | Sell |
14,889
-458
| -3% | -$10.6K | ﹤0.01% | 2027 |
|
|
2023
Q2 | $402K | Buy |
15,347
+2,150
| +16% | +$56.4K | ﹤0.01% | 2002 |
|
|
2023
Q1 | $340K | Buy |
13,197
+1,008
| +8% | +$25.9K | ﹤0.01% | 2058 |
|
|
2022
Q4 | $317K | Buy |
12,189
+2,614
| +27% | +$68K | ﹤0.01% | 2087 |
|
|
2022
Q3 | $273K | Buy |
+9,575
| New | +$273K | ﹤0.01% | 2110 |
|
|
2022
Q2 | – | Sell |
-11,014
| Closed | -$621K | – | 2638 |
|
|
2022
Q1 | $621K | Buy |
11,014
+174
| +2% | +$9.81K | ﹤0.01% | 2071 |
|
|
2021
Q4 | $672K | Sell |
10,840
-5,233
| -33% | -$324K | ﹤0.01% | 2061 |
|
|
2021
Q3 | $1.02M | Buy |
16,073
+102
| +0.6% | +$6.47K | ﹤0.01% | 2002 |
|
|
2021
Q2 | $1.32M | Buy |
15,971
+1,289
| +9% | +$106K | ﹤0.01% | 1988 |
|
|
2021
Q1 | $1.08M | Sell |
14,682
-286
| -2% | -$21K | ﹤0.01% | 1979 |
|
|
2020
Q4 | $1.09M | Buy |
+14,968
| New | +$1.09M | ﹤0.01% | 1928 |
|